15:24 IST
BSE
Other Announcement
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 as per SEBI regulations.
Aarti Pharmalabs Ltd
- Share price
- ₹953.35
- Market cap
- ₹8,645 Cr
- Revenue (annual)
- ₹1,819 Cr
- Net profit (annual)
- ₹174.7 Cr
- P/E (TTM)
- 40.6×Sector 47.3×
- Promoter holding
- 42.86%-0.22% QoQ
- FII holding
- 8.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Selling 5Management Change 4Earnings Call 4Other Announcement 3Financial Results 3Board Meeting Date 3Share Pledge 2Employee Stock Options 2Dividend 2Annual General Meeting 2Production Started 1Legal & Regulatory 1Board Meeting Outcome 1Annual Report 1
Time
3 announcements with these filters
13:17 IST
BSE
Other Announcement
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs Ltd submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed no dematerialisation requests were received during the quarter. This is a routine regulatory disclosure with no material financial impact.
16:56 IST
BSE
Other Announcement
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs Limited launched the 'Saksham Niveshak' campaign from April 1 to July 9, 2026. Initiated by the IEPFA, the drive encourages shareholders to update KYC details and claim unpaid dividends before they are transferred to the Investor Education and Protection Fund.
- Execution
- April 01, 2026 to July 09, 2026